Acridine ester ME-DMAE-NHS is a luminescent reagent with a long chain structure, and its main chemical structure is composed of groups such as maleimide mercaptoethyl and dimethylaminoethyl. This special structure gives it strong affinity on biological macromolecules and can react with amino and thiol groups in proteins and nucleic acids through nucleophilic reactions, achieving effective labeling. The role it plays is roughly as follows: 1. Acridine ester ME-DMAE-NHS is often used for labeling proteins and antibodies in biomedical research. It can react with amino groups (Lysine) in proteins and thiol groups (Cysteine) in antibodies to form stable amide or thioether bonds, introducing chemiluminescence labeling into the target protein or antibody. This marker can play an important role in fields such as biological analysis, immune detection, and drug development. 2. Immunoassay is an important biological analysis technology widely used in early diagnosis of diseases and drug development. Acridine ester ME-DMAE-NHS can be used to introduce fluorescent labels into antibodies, enabling them to bind to specific antigens and generate fluorescent signals, thereby achieving rapid and highly sensitive immune detection. 3. In the field of protein research, acridine ester ME-DMAE-NHS is also widely used to introduce chemiluminescence labeling into proteins for studying the structure, function, and interactions of proteins. Fluorescent labeled proteins can be tracked in real-time within organisms, thereby better understanding the biological functions of proteins. 4. With the continuous development of biomedical research, it has been found that acridine ester ME-DMAE-NHS also has great potential for application in drug analysis. For example, it can undergo chemical reactions with drug molecules, introducing chemiluminescence labeling into drug molecules, thereby achieving fluorescence tracing and monitoring of drugs, providing new methods for drug development and efficacy evaluation.